Healthcare Stocks
988 只股票追踪中 在 Healthcare
| 股票代码 | 公司 | 市值 | P/E | 信号 |
|---|---|---|---|---|
| A | Agilent Technologies, Inc. Common Stock | $33.5B | 26.0 | — |
| AAPG | Ascentage Pharma Group International - American Depository Shares | $19.4B | — | — |
| AARD | Aardvark Therapeutics, Inc. - Common Stock | $95.1M | — | — |
| ABBV | AbbVie Inc. Common Stock | $372.9B | 88.2 | — |
| ABCL | AbCellera Biologics Inc. - Common Shares | $1.2B | — | — |
| ABEO | Abeona Therapeutics Inc. - Common Stock | $324.9M | 4.6 | — |
| ABOS | Acumen Pharmaceuticals, Inc. - Common Stock | $164.7M | — | — |
| ABSI | Absci Corporation - Common Stock | $799.8M | — | — |
| ABT | Abbott Laboratories Common Stock | $165.2B | 26.3 | — |
| ABUS | Arbutus Biopharma Corporation - Common Stock | $837.6M | — | — |
| ABVC | ABVC BioPharma, Inc. - Common Stock | $51.8M | — | — |
| ABVX | Abivax SA - American Depositary Shares | $9.4B | — | — |
| ACAD | ACADIA Pharmaceuticals Inc. - Common Stock | $3.7B | 9.5 | 2 |
| ACB | Aurora Cannabis Inc. - Common Shares | $327.2M | — | — |
| ACET | Adicet Bio, Inc. - Common Stock | $80.7M | — | — |
| ACH | Accendra Health, Inc. Common Stock | $257.2M | — | — |
| ACHC | Acadia Healthcare Company, Inc. - Common Stock | $1.3B | 12.2 | — |
| ACHV | Achieve Life Sciences, Inc. - Common Shares | $563.1M | — | — |
| ACIU | AC Immune SA - Common Stock | $310.7M | — | — |
| ACOG | Alpha Cognition Inc. - Common Stock | $123.7M | — | — |
| ACON | Aclarion, Inc. - Common Stock | $3.1M | — | — |
| ACRS | Aclaris Therapeutics, Inc. - Common Stock | $692.0M | — | — |
| ACRV | Acrivon Therapeutics, Inc. - Common Stock | $70.6M | — | — |
| ACTU | Actuate Therapeutics, Inc. - Common stock | $62.1M | — | — |
| ACXP | Acurx Pharmaceuticals, Inc. - Common Stock | $8.0M | — | — |
| ADAG | Adagene Inc. - ADS, each representing 1.25 ordinary shares | $89.1M | — | — |
| ADCT | ADC Therapeutics SA Common Shares | $442.6M | — | — |
| ADGM | Adagio Medical Holdings, Inc - Common Stock | $20.5M | — | — |
| ADIL | Adial Pharmaceuticals, Inc - Common Stock | $2.1M | — | — |
| ADMA | ADMA Biologics Inc - Common Stock | $1.9B | 11.3 | 2 |
| ADPT | Adaptive Biotechnologies Corporation - Common Stock | $2.5B | — | — |
| ADTX | Aditxt, Inc. - Common Stock | $467K | — | — |
| ADUS | Addus HomeCare Corporation - Common Stock | $1.9B | 19.4 | 2 |
| ADVB | Advanced Biomed Inc. - Common Stock | $6.3M | — | — |
| ADXN | Addex Therapeutics Ltd - American Depositary Shares | $8.1M | — | — |
| AEMD | Aethlon Medical, Inc. - Common Stock | $2.1M | — | — |
| AGEN | Agenus Inc. - Common Stock | $131.3M | 1141.9 | — |
| AGIO | Agios Pharmaceuticals, Inc. - Common Stock | $1.6B | — | — |
| AGL | agilon health, inc. Common Stock | $513.8M | — | — |
| AHCO | AdaptHealth Corp. - Common Stock | $1.5B | — | — |
| AHG | Akso Health Group - American Depositary Shares | $905.1M | — | — |
| AIFF | Firefly Neuroscience, Inc. - Common Stock | $11.8M | — | — |
| AIRS | AirSculpt Technologies, Inc. - Common Stock | $251.8M | — | — |
| AIXC | AIxCrypto Holdings, Inc. - Common Stock | $12.1M | — | — |
| AKAN | Akanda Corp. - Common Shares | $333K | — | — |
| AKBA | Akebia Therapeutics, Inc. - Common Stock | $311.2M | — | — |
| AKTX | Akari Therapeutics Plc - American Depositary Shares | $4.0M | — | — |
| ALC | Alcon Inc. Ordinary Shares | $31.6B | 41.1 | — |
| ALDX | Aldeyra Therapeutics, Inc. - Common Stock | $106.8M | — | — |
| ALEC | Alector, Inc. - Common Stock | $170.3M | — | — |
| ALGN | Align Technology, Inc. - Common Stock | $11.2B | 29.6 | 2 |
| ALGS | Aligos Therapeutics, Inc. - Common stock | $57.4M | — | — |
| ALHC | Alignment Healthcare, Inc. - Common Stock | $4.0B | — | — |
| ALKS | Alkermes plc - Ordinary Shares | $4.6B | 13.6 | 1 |
| ALLO | Allogene Therapeutics, Inc. - Common Stock | $771.9M | — | — |
| ALLR | Allarity Therapeutics, Inc. - Common stock | $21.4M | — | — |
| ALMS | Alumis Inc. - Common Stock | $2.9B | — | — |
| ALNY | Alnylam Pharmaceuticals, Inc. - Common Stock | $52.5B | 1205.9 | — |
| ALPS | ALPS Group Inc - Ordinary Share | $144.7M | — | — |
| ALT | Altimmune, Inc. - Common Stock | $595.7M | — | — |
| ALVO | Alvotech - Ordinary Shares | $1.1B | 39.9 | — |
| ALXO | ALX Oncology Holdings Inc. - Common Stock | $61.3M | — | — |
| ALZN | Alzamend Neuro, Inc. - Common Stock | $6.9M | — | — |
| AMGN | Amgen Inc. - Common Stock | $176.3B | 25.2 | 5 |
| AMIX | Autonomix Medical, Inc. - Common Stock | $3.8M | — | — |
| AMLX | Amylyx Pharmaceuticals, Inc. - Common Stock | $1.8B | — | — |
| AMN | AMN Healthcare Services Inc | $790.5M | — | — |
| AMPH | Amphastar Pharmaceuticals, Inc. - Common Stock | $808.9M | 8.2 | 1 |
| AMRN | Amarin Corporation plc - American Depositary Shares | $281.0M | — | — |
| AMRX | Amneal Pharmaceuticals, Inc. - Class A Common Stock | $4.0B | 671.4 | — |
| AMWL | American Well Corporation Class A Common Stock | $102.5M | — | — |
| ANAB | AnaptysBio, Inc. - Common Stock | $1.8B | — | — |
| ANGO | AngioDynamics, Inc. - Common Stock | $529.0M | — | — |
| ANIK | Anika Therapeutics Inc. - Common Stock | $196.1M | — | — |
| ANIP | ANI Pharmaceuticals, Inc. - Common Stock | $1.9B | 24.3 | — |
| ANIX | Anixa Biosciences, Inc. - Common Stock | $102.7M | — | — |
| ANL | Adlai Nortye Ltd. - American Depositary Shares | $52.4M | — | — |
| ANNX | Annexon, Inc. - common stock | $846.7M | — | — |
| ANRO | Alto Neuroscience, Inc. Common Stock | $832.5M | — | — |
| ANTX | AN2 Therapeutics, Inc. - Common Stock | $169.9M | — | — |
| ANVS | Annovis Bio, Inc. Common Stock | $71.1M | — | — |
| AORT | Artivion, Inc. Common Stock | $1.8B | 183.1 | — |
| APGE | Apogee Therapeutics, Inc. - Common Stock | $6.3B | — | — |
| APLM | Apollomics Inc. - Class A Ordinary Shares | $20.6M | — | — |
| APM | Aptorum Group Limited - Class A Ordinary Shares | $8.6M | — | — |
| APRE | Aprea Therapeutics, Inc. - Common Stock | $11.1M | — | — |
| APVO | Aptevo Therapeutics Inc. - Common Stock | $5.8M | — | — |
| APYX | Apyx Medical Corporation - Common Stock | $143.6M | — | — |
| AQB | AquaBounty Technologies, Inc. - Common Stock | $3.6M | — | — |
| AQST | Aquestive Therapeutics, Inc. - Common Stock | $510.2M | — | — |
| ARAY | Accuray Incorporated - Common Stock | $93.5M | — | — |
| ARCT | Arcturus Therapeutics Holdings Inc. - Common Stock | $262.1M | — | — |
| ARDT | Ardent Health, Inc. Common Stock | $1.4B | 10.5 | — |
| ARDX | Ardelyx, Inc. - Common Stock | $1.4B | — | — |
| ARGX | argenx SE - American Depositary Shares | $44.1B | 33.8 | — |
| ARQT | Arcutis Biotherapeutics, Inc. - Common stock | $3.6B | — | — |
| ARTL | Artelo Biosciences, Inc. - Common Stock | $2.5M | — | — |
| ARTV | Artiva Biotherapeutics, Inc. - Common Stock | $269.2M | — | — |
| ARVN | Arvinas, Inc. - Common Stock | $761.7M | — | — |
| ARWR | Arrowhead Pharmaceuticals, Inc. - Common Stock | $9.0B | — | — |
| ASBP | Aspire Biopharma Holdings, Inc. - Common Stock | $18.3M | — | — |
| ASMB | Assembly Biosciences, Inc. - Common Stock | $472.6M | — | — |
| ASND | Ascendis Pharma A/S - American Depositary Shares | $12.8B | — | — |
| ASRT | Assertio Holdings, Inc. - Common Stock | $145.0M | — | — |
| ASTH | Astrana Health Inc. - Common Stock | $1.9B | 64.0 | — |
| ATAI | AtaiBeckley Inc. - Common Stock | $1.5B | — | — |
| ATEC | Alphatec Holdings, Inc. - Common Stock | $3.1B | — | — |
| ATHE | Alterity Therapeutics Limited - American Depositary Shares | $87.0M | — | — |
| ATLN | Atlantic International Corp. - Common Stock | $77.8M | — | — |
| ATOS | Atossa Therapeutics, Inc. - Common Stock | $48.2M | — | — |
| ATPC | Agape ATP Corporation - Common Stock | $5.3M | — | — |
| ATRA | Atara Biotherapeutics, Inc. - Common Stock | $86.3M | 2.6 | — |
| ATRC | AtriCure, Inc. - Common Stock | $2.0B | — | — |
| ATYR | aTyr Pharma, Inc. - Common Stock | $49.4M | — | — |
| AUNA | Auna SA Class A Ordinary Shares | $351.6M | 12.3 | — |
| AUPH | Aurinia Pharmaceuticals Inc - Common Shares | $2.0B | 7.1 | — |
| AURA | Aura Biosciences, Inc. - Common Stock | $800.2M | — | — |
| AUTL | Autolus Therapeutics plc - American Depositary Shares | $455.1M | — | — |
| AVAH | Aveanna Healthcare Holdings Inc. - Common Stock | $1.5B | 6.5 | 1 |
| AVBP | ArriVent BioPharma, Inc. - Common Stock | $1.3B | — | — |
| AVIR | Atea Pharmaceuticals, Inc. - common stock | $431.0M | — | — |
| AVNS | Avanos Medical, Inc. Common Stock | $1.1B | — | — |
| AVR | Anteris Technologies Global Corp. - Common Stock | $633.0M | — | — |
| AVTR | Avantor, Inc. Common Stock | $5.6B | — | — |
| AVTX | Avalo Therapeutics, Inc. - Common Stock | $842.1M | — | — |
| AVXL | Anavex Life Sciences Corp. - Common Stock | $318.1M | — | — |
| AXGN | Axogen, Inc. - Common Stock | $2.3B | — | — |
| AXSM | Axsome Therapeutics, Inc. - Common Stock | $9.2B | — | — |
| AYTU | Aytu BioPharma, Inc. - Common Stock | $24.1M | — | — |
| AZN | AstraZeneca PLC - American Depositary Shares | $213.8B | 30.6 | 3 |
| AZTA | Azenta, Inc. - Common Stock | $1.5B | — | — |
| BAX | Baxter International Inc. Common Stock | $9.3B | — | — |
| BBIO | BridgeBio Pharma, Inc. - Common Stock | $14.7B | — | — |
| BBLG | Bone Biologics Corp - Common Stock | $2.3M | — | — |
| BBNX | Beta Bionics, Inc. - Common Stock | $1.3B | — | — |
| BBOT | BridgeBio Oncology Therapeutics, Inc. - Common Stock | $632.1M | 134.0 | — |
| BCAB | BioAtla, Inc. - Common Stock | $33.5M | — | — |
| BCAX | Bicara Therapeutics Inc. - Common Stock | $1.3B | — | — |
| BCDA | BioCardia, Inc. - Common Stock | $11.9M | — | — |
| BCRX | BioCryst Pharmaceuticals, Inc. - Common Stock | $1.6B | — | — |
| BCTX | BriaCell Therapeutics Corp. - Common Shares | $18.5M | — | — |
| BCYC | Bicycle Therapeutics plc - American Depositary Shares | $471.3M | — | — |
| BDMD | Baird Medical Investment Holdings Ltd - Ordinary Share | $48.6M | 41.9 | — |
| BDRX | Biodexa Pharmaceuticals plc - American Depositary Shares | $1.4M | — | — |
| BDSX | Biodesix, Inc. - Common Stock | $154.9M | — | — |
| BDTX | Black Diamond Therapeutics, Inc. - Common Stock | $162.2M | — | — |
| BDX | Becton, Dickinson and Company Common Stock | $44.1B | 25.1 | — |
| BEAM | Beam Therapeutics Inc. - Common Stock | $3.3B | — | — |
| BEAT | Heartbeam, Inc. - Common Stock | $54.2M | — | — |
| BFLY | Butterfly Network, Inc. Class A Common Stock | $1.3B | — | — |
| BFRG | Bullfrog AI Holdings, Inc. - Common Stock | $10.1M | — | — |
| BFRI | Biofrontera Inc. - Common Stock | $11.2M | — | — |
| BGM | BGM Group Ltd. - Class A Ordinary Shares | $678.8M | — | — |
| BGMS | Bio Green Med Solution, Inc. - Common Stock | $7.3M | — | — |
| BHC | Bausch Health Companies Inc. Common Stock | $2.9B | 13.6 | — |
| BHVN | Biohaven Ltd. Common Shares | $1.5B | — | — |
| BIAF | bioAffinity Technologies, Inc. - Common Stock | $5.3M | — | — |
| BIIB | Biogen Inc. - Common Stock | $25.8B | 16.0 | 2 |
| BIO | Bio-Rad Laboratories, Inc. Class A Common Stock | $7.9B | 10.4 | — |
| BIOA | BioAge Labs, Inc. - Common Stock | $798.7M | — | — |
| BIVI | BioVie Inc. - Common stock | $8.7M | — | — |
| BJDX | Bluejay Diagnostics, Inc. - Common Stock | $1.2M | — | — |
| BKD | Brookdale Senior Living Inc. Common Stock | $3.3B | — | — |
| BLCO | Bausch + Lomb Corporation Common Shares | $5.9B | — | — |
| BLFS | BioLife Solutions, Inc. - Common Stock | $1.1B | — | — |
| BLLN | BillionToOne, Inc. - Class A common stock | $3.6B | 486.1 | — |
| BLRX | BioLineRx Ltd. - American Depositary Shares | $41.8M | — | — |
| BLTE | Belite Bio, Inc - American Depositary Shares | $5.6B | — | — |
| BMEA | Biomea Fusion, Inc. - Common Stock | $87.7M | — | — |
| BMGL | Basel Medical Group Ltd - ordinary shares | $9.2M | — | — |
| BMRA | Biomerica, Inc. - Common Stock | $7.4M | — | — |
| BMRN | BioMarin Pharmaceutical Inc. - Common Stock | $11.4B | 21.9 | 3 |
| BMY | Bristol-Myers Squibb Company Common Stock | $119.0B | 16.9 | — |
| BNBX | BNB Plus Corp. - Common Stock | $5.4M | — | — |
| BNGO | Bionano Genomics, Inc. - Common Stock | $13.9M | — | — |
| BNR | Burning Rock Biotech Limited - American Depositary Shares | $216.9M | — | — |
| BNTC | Benitec Biopharma Inc. - Common Stock | $394.7M | — | — |
| BNTX | BioNTech SE - American Depositary Shares | $22.9B | — | 2 |
| BOLD | Boundless Bio, Inc. - Common Stock | $33.5M | — | — |
| BOLT | Bolt Biotherapeutics, Inc. - Common Stock | $9.2M | — | — |
| BRKR | Bruker Corporation - Common Stock | $7.2B | — | — |
| BRKRP | Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A | $7.2B | — | — |
| BRNS | Barinthus Biotherapeutics plc - American Depositary Shares | $28.6M | — | — |
| BRTX | BioRestorative Therapies, Inc. - Common Stock | $4.9M | — | — |
| BSX | Boston Scientific Corporation Common Stock | $94.9B | 32.7 | — |
| BTAI | BioXcel Therapeutics, Inc. - Common Stock | $30.9M | — | — |
| BTMD | Biote Corp. - Class A common stock | $85.7M | 3.2 | — |
| BTSG | BrightSpring Health Services, Inc. - Common Stock | $6.8B | 52.1 | 2 |
| BTSGU | BrightSpring Health Services, Inc. - Tangible Equity Unit | $6.8B | 52.1 | — |
| BVS | Bioventus Inc. - Class A Common Stock | $876.0M | 38.5 | — |
| BWAY | BrainsWay Ltd. - American Depositary Shares | $1.2B | 61.5 | — |
| BYSI | BeyondSpring, Inc. - Ordinary Shares | $57.6M | — | — |
| CABA | Cabaletta Bio, Inc. - Common Stock | $539.7M | — | — |
| CADL | Candel Therapeutics, Inc. - Common Stock | $642.4M | — | — |
| CAH | Cardinal Health, Inc. Common Stock | $50.1B | 30.1 | — |
| CAI | Caris Life Sciences, Inc. - Common Stock | $7.6B | — | — |
| CALC | CalciMedica, Inc. - Common Stock | $10.4M | — | — |
| CAMP | CAMP4 Therapeutics Corporation - Common Stock | $231.6M | — | — |
| CAPR | Capricor Therapeutics, Inc. - Common Stock | $1.8B | — | — |
| CARL | Carlsmed, Inc. - Common Stock | $328.4M | — | — |
| CBIO | Crescent Biopharma, Inc. - Common Stock | $164.8M | — | — |
| CBLL | CeriBell, Inc. - Common Stock | $759.7M | — | — |
| CBUS | Cibus, Inc. - Class A Common Stock | $107.6M | — | — |
| CCCC | C4 Therapeutics, Inc. - Common Stock | $185.1M | — | — |
| CCLD | CareCloud, Inc. - Common Stock | $123.8M | 11.0 | — |
| CCM | Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares) | $17.0M | — | — |
| CCRN | Cross Country Healthcare, Inc. - Common Stock | $265.4M | — | — |
| CDIO | Cardio Diagnostics Holdings Inc. - Common stock | $4.9M | — | — |
| CDNA | CareDx, Inc. - Common Stock | $969.0M | 15.9 | — |
| CDT | CDT Equity Inc. - Common Stock | $2.1M | — | — |
| CDXS | Codexis, Inc. - Common Stock | $259.1M | — | — |
| CELC | Celcuity Inc. - Common Stock | $6.5B | — | — |
| CELU | Celularity Inc. - Class A Common Stock | $27.6M | — | — |
| CELZ | Creative Medical Technology Holdings, Inc. - Common Stock | $8.5M | — | — |
| CERS | Cerus Corporation - Common Stock | $395.7M | — | — |
| CERT | Certara, Inc. - Common Stock | $967.5M | — | — |
| CGC | Canopy Growth Corporation - Common Shares | $574.8M | — | — |
| CGEM | Cullinan Therapeutics, Inc. - Common Stock | $918.1M | — | — |
| CGEN | Compugen Ltd. - Ordinary Shares | $260.0M | 7.4 | — |
| CGON | CG Oncology, Inc. - Common stock | $5.9B | — | — |
| CGTX | Cognition Therapeutics, Inc. - Common Stock | $102.0M | — | — |
| CHE | Chemed Corp | $5.3B | 19.9 | — |
| CHRS | Coherus Oncology, Inc. - Common Stock | $289.9M | 1.7 | — |
| CI | The Cigna Group Common Stock | $73.6B | 12.4 | — |
| CING | Cingulate Inc. - Common Stock | $56.0M | — | — |
| CLDX | Celldex Therapeutics, Inc. - Common Stock | $1.8B | — | — |
| CLGN | CollPlant Biotechnologies Ltd. - Ordinary Shares | $17.8M | — | — |
| CLLS | Cellectis S.A. - American Depositary Shares | $303.4M | — | — |
| CLNN | Clene Inc. - Common Stock | $84.1M | — | — |
| CLOV | Clover Health Investments, Corp. - Class A Common stock | $1.2B | — | — |
| CLPT | ClearPoint Neuro Inc. - Common Stock | $365.5M | — | — |
| CLRB | Cellectar Biosciences, Inc. - Common Stock | $13.1M | — | — |
| CLYM | Climb Bio, Inc. - Common Stock | $618.4M | — | — |
| CMMB | Chemomab Therapeutics Ltd. - American Depositary Shares | $12.2M | — | — |
| CMND | Clearmind Medicine Inc. - Common Shares | $2.7M | — | — |
| CMPS | COMPASS Pathways Plc - American Depository Shares | $927.2M | — | — |
| CMPX | Compass Therapeutics, Inc. - Common Stock | $329.6M | — | — |
| CNC | Centene Corporation Common Stock | $19.2B | — | — |
| CNMD | CONMED Corporation Common Stock | $1.2B | 24.8 | — |
| CNSP | CNS Pharmaceuticals, Inc. - Common Stock | $4.0M | — | — |
| CNTA | Centessa Pharmaceuticals plc - American Depositary Shares | $6.1B | — | — |
| CNTB | Connect Biopharma Holdings Limited - Ordinary Shares | $149.9M | — | — |
| CNTX | Context Therapeutics Inc. - Common Stock | $219.6M | — | — |
| COCH | Envoy Medical, Inc. - Class A Common Stock | $54.9M | — | — |
| COCP | Cocrystal Pharma, Inc. - Common Stock | $16.5M | — | — |
| CODX | Co-Diagnostics, Inc. - Common Stock | $5.9M | — | — |
| COGT | Cogent Biosciences, Inc. - Common Stock | $5.9B | — | — |
| COLL | Collegium Pharmaceutical, Inc. - Common Stock | $1.2B | 18.8 | 1 |
| CON | Concentra Group Holdings Parent, Inc. Common Stock | $2.9B | 17.2 | — |
| COO | The Cooper Companies, Inc. - Common Stock | $16.1B | 42.8 | 1 |
| COR | Cencora, Inc. Common Stock | $62.7B | 38.6 | — |
| CORT | Corcept Therapeutics Incorporated - Common Stock | $3.7B | 34.5 | — |
| COSM | Cosmos Health Inc. - Common Stock | $18.6M | — | — |
| COYA | Coya Therapeutics, Inc. - Common Stock | $116.3M | — | — |
| CPIX | Cumberland Pharmaceuticals Inc. - Common Stock | $68.2M | — | — |
| CPRX | Catalyst Pharmaceuticals, Inc. - Common Stock | $3.8B | 17.8 | 2 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $142.9M | — | — |
| CRBU | Caribou Biosciences, Inc. - Common Stock | $148.6M | — | — |
| CRDF | Cardiff Oncology, Inc. - Common Stock | $114.2M | — | — |
| CRDL | Cardiol Therapeutics Inc. - Class A Common Shares | $131.0M | — | — |
| CRIS | Curis, Inc. - Common Stock | $12.8M | — | — |
| CRL | Charles River Laboratories International, Inc. Common Stock | $8.8B | — | — |
| CRMD | CorMedix Inc. - Common Stock | $588.2M | 3.6 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock | $4.6B | — | — |
| CRON | Cronos Group Inc. - Common Share | $1.4B | 27.8 | — |
| CRSP | CRISPR Therapeutics AG - Common Shares | $5.0B | — | — |
| CRVL | CorVel Corp. - Common Stock | $3.0B | 28.8 | 1 |
| CRVO | CervoMed Inc. - Common Stock | $31.8M | — | — |
| CRVS | Corvus Pharmaceuticals, Inc. - Common Stock | $1.3B | — | — |
| CSBR | Champions Oncology, Inc. - Common Stock | $96.0M | 32.5 | 1 |
| CSTL | Castle Biosciences, Inc. - Common stock | $601.4M | — | — |
| CTEV | Claritev Corporation Class A Common Stock | $333.4M | — | — |
| CTKB | Cytek Biosciences, Inc. - Common Stock | $532.1M | — | — |
| CTMX | CytomX Therapeutics, Inc. - Common Stock | $860.4M | — | — |
| CTNM | Contineum Therapeutics, Inc. - Common stock | $510.7M | — | — |
| CTOR | Citius Oncology, Inc. - Common Stock | $85.0M | — | — |
| CTSO | Cytosorbents Corporation - Common Stock | $38.3M | — | — |
| CTXR | Citius Pharmaceuticals, Inc. - Common Stock | $16.1M | — | — |
| CUE | Cue Biopharma, Inc. - Common Stock | $27.9M | — | — |
| CUPR | Cuprina Holdings (Cayman) Limited - Ordinary shares | $2.9M | — | — |
| CURX | Curanex Pharmaceuticals Inc - Common Stock | $9.4M | — | — |
| CV | CapsoVision, Inc. - Common Stock | $348.9M | — | — |
| CVKD | Cadrenal Therapeutics, Inc. - Common Stock | $18.7M | — | — |
| CVRX | CVRx, Inc. - Common Stock | $186.1M | — | — |
| CVS | CVS Health Corporation Common Stock | $98.6B | 55.8 | — |
| CYCN | Cyclerion Therapeutics, Inc. - Common Stock | $5.0M | — | — |
| CYH | Community Health Systems, Inc. Common Stock | $434.6M | 0.9 | — |
| CYPH | Cypherpunk Technologies Inc. - Common Stock | $65.7M | — | — |
| CYRX | CryoPort, Inc. - Common Stock | $480.7M | 7.1 | — |
| CYTK | Cytokinetics, Incorporated - Common Stock | $7.8B | — | — |
| DARE | Dare Bioscience, Inc. - Common Stock | $41.6M | — | — |
| DBVT | DBV Technologies S.A. - American Depositary Shares | $678.3M | — | — |
| DCGO | DocGo Inc. - Common Stock | $58.5M | — | — |
| DCTH | Delcath Systems, Inc. - Common Stock | $381.8M | 680.6 | — |
| DERM | Journey Medical Corporation - Common Stock | $141.8M | — | — |
| DGX | Quest Diagnostics Incorporated Common Stock | $21.1B | 21.2 | — |
| DH | Definitive Healthcare Corp. - Class A Common Stock | $406.5M | — | — |
| DHR | Danaher Corporation Common Stock | $136.8B | 37.9 | — |
| DMAC | DiaMedica Therapeutics Inc. - Common Stock | $340.5M | — | — |
| DNA | Ginkgo Bioworks Holdings, Inc. Class A Common Stock | $487.8M | — | — |
| DNLI | Denali Therapeutics Inc. - Common Stock | $2.6B | — | — |
| DNTH | Dianthus Therapeutics, Inc. - Common Stock | $4.7B | — | — |
| DOCS | Doximity, Inc. Class A Common Stock | $4.5B | 18.7 | — |
| DRIO | DarioHealth Corp. - Common Stock | $60.7M | — | — |
| DRMA | Dermata Therapeutics, Inc. - Common Stock | $4.8M | — | — |
| DRTS | Alpha Tau Medical Ltd. - Ordinary Shares | $882.7M | — | — |
| DRUG | Bright Minds Biosciences Inc. - common stock | $859.9M | — | — |
| DSGN | Design Therapeutics, Inc. - Common Stock | $888.1M | — | — |
| DTIL | Precision BioSciences, Inc. - Common Stock | $211.6M | — | — |
| DVA | DaVita Inc. Common Stock | $12.8B | 17.1 | — |
| DWTX | Dogwood Therapeutics, Inc. - Common Stock | $62.1M | — | — |
| DXCM | DexCom, Inc. - Common Stock | $25.9B | 35.9 | 3 |
| DXR | Daxor Corporation - Closed End Fund | $68.9M | 38.3 | — |
| DYAI | Dyadic International, Inc. - Common Stock | $25.9M | — | — |
| DYN | Dyne Therapeutics, Inc. - Common Stock | $3.2B | — | — |
| EBS | Emergent BioSolutions Inc. Common Stock | $441.1M | — | — |
| ECOR | electroCore, Inc. - Common Stock | $35.9M | — | — |
| EDAP | EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share | $156.3M | — | — |
| EDIT | Editas Medicine, Inc. - Common Stock | $304.5M | — | — |
| EDSA | Edesa Biotech, Inc. - Common Shares | $116.0M | — | — |
| EHC | Encompass Health Corporation Common Stock | $10.5B | 18.5 | — |
| ELAN | Elanco Animal Health Incorporated Common Stock | $10.7B | — | — |
| ELDN | Eledon Pharmaceuticals, Inc. - Common Stock | $293.3M | — | — |
| ELTX | Elicio Therapeutics, Inc. - Common Stock | $182.7M | — | — |
| ELUT | Elutia, Inc. - Class A Common Stock | $46.4M | 0.9 | — |
| ELV | Elevance Health, Inc. Common Stock | $70.9B | 12.5 | — |
| ELVN | Enliven Therapeutics, Inc. - Common Stock | $2.4B | — | — |
| EMBC | Embecta Corp. - Common Stock | $703.4M | 7.4 | — |
| ENGN | enGene Holdings Inc. - Common Stock | $604.9M | — | — |
| ENLV | Enlivex Therapeutics Ltd. - Ordinary Shares | $17.1M | — | — |
| ENOV | Enovis Corporation Common Stock | $1.5B | — | — |
| ENSC | Ensysce Biosciences, Inc. - Common Stock | $2.6M | — | — |
| ENSG | The Ensign Group, Inc. - Common Stock | $10.1B | 30.7 | 1 |
| ENTA | Enanta Pharmaceuticals, Inc. - Common Stock | $455.2M | — | — |
| ENTX | Entera Bio Ltd. - Ordinary Shares | $60.6M | — | — |
| ENVB | Enveric Biosciences, Inc. - Common Stock | $2.2M | — | — |
| EOLS | Evolus, Inc. - Common Stock | $419.5M | — | — |
| EPRX | Eupraxia Pharmaceuticals Inc. - Common Stock | $522.7M | — | — |
| EQ | Equillium, Inc. - Common Stock | $146.1M | — | — |
| ERAS | Erasca, Inc. - Common Stock | $3.2B | — | — |
| ERNA | Ernexa Therapeutics Inc. - Common Stock | $9.4M | — | — |
| ESLA | Estrella Immunopharma, Inc. - Common Stock | $58.9M | — | — |
| ESPR | Esperion Therapeutics, Inc. - Common Stock | $805.7M | — | — |
| ESTA | Establishment Labs Holdings Inc. - Common Shares | $2.1B | — | — |
| ETON | Eton Pharmaceuticals, Inc. - Common Stock | $819.7M | — | — |
| EUDA | Euda Health Holdings Limited - Ordinary Shares | $87.3M | — | — |
| EVAX | Evaxion A/S - American Depositary Share | $38.1M | — | — |
| EVGN | Evogene Ltd. - Ordinary Shares | $8.7M | — | — |
| EVH | Evolent Health, Inc Class A Common Stock | $333.8M | — | — |
| EVMN | Evommune, Inc. Common Stock | $964.2M | — | — |
| EVO | Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share | $967.5M | — | — |
| EW | Edwards Lifesciences Corporation Common Stock | $45.4B | 42.3 | — |
| EWTX | Edgewise Therapeutics, Inc. - Common Stock | $4.1B | — | — |
| EXEL | Exelixis, Inc. - Common Stock | $12.1B | 15.5 | 3 |
| EXOZ | eXoZymes Inc. - Common Stock | $91.4M | — | — |
| EYPT | EyePoint, Inc. - Common Stock | $1.5B | — | — |
| FATE | Fate Therapeutics, Inc. - Common Stock | $204.6M | — | — |
| FBIO | Fortress Biotech, Inc. - Common Stock | $113.6M | 28.5 | — |
| FBIOP | Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | $113.6M | 28.5 | — |
| FBLG | FibroBiologics, Inc. - Common Stock | $5.5M | — | — |
| FBRX | Forte Biosciences, Inc. - Common Stock | $410.9M | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. - Common Stock | $544.7M | — | — |
| FEMY | Femasys Inc. - Common Stock | $26.0M | — | — |
| FENC | Fennec Pharmaceuticals Inc. - Common Stock | $236.3M | — | — |
| FHTX | Foghorn Therapeutics Inc. - Common Stock | $260.6M | — | — |
| FLGT | Fulgent Genetics, Inc. - Common Stock | $812.1M | — | — |
| FMS | Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) | $11.3B | 11.6 | — |
| FONR | Fonar Corporation - Common Stock | $117.1M | 15.7 | — |
| FTRE | Fortrea Holdings Inc. - Common Stock | $1.3B | — | — |
| FULC | Fulcrum Therapeutics, Inc. - Common Stock | $746.1M | — | — |
| GALT | Galectin Therapeutics Inc. - Common Stock | $142.8M | — | — |
| GANX | Gain Therapeutics, Inc. - Common Stock | $74.6M | — | — |
| GCTK | GlucoTrack, Inc. - Common Stock | $3.5M | — | — |
| GDRX | GoodRx Holdings, Inc. - Class A Common Stock | $1.0B | 32.9 | — |
| GDTC | CytoMed Therapeutics Limited - Ordinary Shares | $15.7M | — | — |
| GEHC | GE HealthCare Technologies Inc. - Common Stock | $37.4B | 16.9 | 5 |
| GELS | Gelteq Limited - Ordinary Shares | $8.6M | — | — |
| GERN | Geron Corporation - Common Stock | $842.6M | — | — |
| GH | Guardant Health, Inc. - Common Stock | $13.2B | — | — |
| GHRS | GH Research PLC - Ordinary Shares | $1.5B | — | — |
| GILD | Gilead Sciences, Inc. - Common Stock | $152.3B | 18.8 | 4 |
| GKOS | Glaukos Corporation Common Stock | $7.1B | — | — |
| GLMD | Galmed Pharmaceuticals Ltd. - Ordinary Shares | $4.1M | — | — |
| GLSI | Greenwich LifeSciences, Inc. - Common stock | $291.1M | — | — |
| GLUE | Monte Rosa Therapeutics, Inc. - Common Stock | $1.5B | — | — |
| GMAB | Genmab A/S - American Depositary Shares | $124.8B | 13.3 | 2 |
| GMED | Globus Medical, Inc. Class A Common Stock | $10.5B | 17.9 | — |
| GNLX | Genelux Corporation - Common Stock | $130.0M | — | — |
| GNPX | Genprex, Inc. - Common Stock | $7.8M | — | — |
| GNTA | Genenta Science S.p.A. - American Depositary Shares | $28.5M | — | — |
| GOSS | Gossamer Bio, Inc. - Common Stock | $79.8M | — | — |
| GOVX | GeoVax Labs, Inc. - Common Stock | $3.6M | — | — |
| GPCR | Structure Therapeutics Inc. - American Depositary Shares | $2.8B | — | — |
| GRAL | GRAIL, Inc. - Common Stock | $2.6B | — | — |
| GRCE | Grace Therapeutics, Inc. - Common Stock | $53.5M | — | — |
| GRDN | Guardian Pharmacy Services, Inc. Class A Common Stock | $2.3B | 47.5 | — |
| GRDX | GridAI Technologies Corp. - Common Stock | — | — | — |
| GRFS | Grifols, S.A. - American Depositary Shares | $6.5B | 17.5 | — |
| GRI | GRI Bio, Inc. - Common Stock | $3.3M | — | — |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | $85.1B | 14.9 | — |
| GTBP | GT Biopharma, Inc. - Common Stock | $12.4M | — | — |
| GUTS | Fractyl Health, Inc. - Common Stock | $122.0M | — | — |
| GYRE | Gyre Therapeutics, Inc. - Common Stock | $724.5M | 144.1 | — |
| HAE | Haemonetics Corporation Common Stock | $2.8B | 16.0 | — |
| HALO | Halozyme Therapeutics, Inc. - Common Stock | $8.3B | 26.3 | 3 |
| HBIO | Harvard Bioscience, Inc. - Common Stock | $31.1M | — | — |
| HCA | HCA Healthcare, Inc. Common Stock | $108.0B | 15.9 | — |
| HCAT | Health Catalyst, Inc - Common stock | $101.5M | — | — |
| HCM | HUTCHMED (China) Limited - American Depositary Shares | $18.0B | 5.0 | — |
| HCTI | Healthcare Triangle, Inc. - Common Stock | $3.7M | — | — |
| HCWB | HCW Biologics Inc. - Common Stock | $9.0M | — | — |
| HIMS | Hims & Hers Health, Inc. Class A Common Stock | $6.6B | 51.7 | — |
| HIND | Vyome Holdings, Inc. - Common Stock | $19.4M | — | — |
| HITI | High Tide Inc. - Common Shares | $319.7M | — | — |
| HLN | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | $31.4B | 18.9 | — |
| HNGE | Hinge Health, Inc. Class A Common Stock | $3.4B | — | — |
| HOTH | Hoth Therapeutics, Inc. - Common Stock | $15.4M | — | — |
| HOWL | Werewolf Therapeutics, Inc. - Common Stock | $30.8M | — | — |
| HQY | HealthEquity, Inc. - Common Stock | $7.8B | 40.8 | 5 |
| HRMY | Harmony Biosciences Holdings, Inc. - Common Stock | $2.2B | 11.6 | — |
| HROW | Harrow, Inc. - Common Stock | $1.4B | — | — |
| HRTX | Heron Therapeutics, Inc. - Common Stock | $238.4M | — | — |
| HSCS | HeartSciences Inc. - Common Stock | $9.8M | — | — |
| HSDT | Solana Company - Class A Common Stock | $133.5M | — | — |
| HSIC | Henry Schein, Inc. - Common Stock | $7.9B | 19.8 | 2 |
| HSTM | HealthStream, Inc. - Common Stock | $684.4M | 33.1 | 1 |
| HTFL | Heartflow, Inc. - Common Stock | $2.7B | — | — |
| HUM | Humana Inc. Common Stock | $24.0B | 20.2 | — |
| HUMA | Humacyte, Inc. - Common Stock | $222.0M | — | — |
| HURA | TuHURA Biosciences, Inc. - Common Stock | $147.1M | — | — |
| HYFT | MindWalk Holdings Corp. - Common Stock | $85.0M | — | — |
| HYPD | Hyperion DeFi, Inc. - Common Stock | $40.4M | — | — |
| HYPR | Hyperfine, Inc. - Class A Common Stock | $172.4M | — | — |
| IART | Integra LifeSciences Holdings Corporation - Common Stock | $967.4M | — | — |
| IBIO | iBio, Inc. - Common Stock | $43.4M | — | — |
| IBRX | ImmunityBio, Inc. - Common Stock | $8.7B | — | — |
| ICCC | ImmuCell Corporation - Common Stock | $76.4M | — | — |
| ICCM | IceCure Medical Ltd. - Ordinary Shares | $15.9M | — | — |
| ICLR | ICON plc - Ordinary Shares | $13.9B | 23.2 | — |
| ICU | SeaStar Medical Holding Corporation - Common Stock | $19.3M | — | — |
| ICUI | ICU Medical, Inc. - Common Stock | $3.5B | — | — |
| IDXX | IDEXX Laboratories, Inc. - Common Stock | $54.0B | 52.6 | 5 |
| IDYA | IDEAYA Biosciences, Inc. - Common Stock | $3.0B | — | — |
| IFRX | InflaRx N.V. - Common Stock | $67.8M | — | — |
| IKT | Inhibikase Therapeutics, Inc. - Common Stock | $253.5M | — | — |
| ILMN | Illumina, Inc. - Common Stock | $20.0B | 28.5 | 1 |
| IMA | ImageneBio, Inc. - Common Stock | $59.2M | — | — |
| IMCC | IM Cannabis Corp. - Common Shares | $10.6M | — | — |
| IMCR | Immunocore Holdings plc - American Depositary Shares | $1.8B | — | — |
| IMDX | Insight Molecular Diagnostics Inc. - Common Stock | $163.2M | — | — |
| IMMP | Immutep Limited - American Depositary Shares | $611.6M | — | — |
| IMMX | Immix Biopharma, Inc. - Common Stock | $516.9M | — | — |
| IMNM | Immunome, Inc. - Common Stock | $2.6B | — | — |
| IMNN | Imunon, Inc. - Common Stock | $10.6M | — | — |
| IMRN | Immuron Limited - American Depositary Shares | $11.8M | — | — |
| IMRX | Immuneering Corporation - Class A Common Stock | $333.8M | — | — |
| IMTX | Immatics N.V. - Ordinary Shares | $1.5B | — | — |
| IMUX | Immunic, Inc. - Common Stock | $162.1M | — | — |
| IMVT | Immunovant, Inc. - Common Stock | $7.2B | — | — |
| INAB | IN8bio, Inc. - Common Stock | $10.8M | — | — |
| INBS | Intelligent Bio Solutions Inc. - Common Stock | $9.1M | — | — |
| INBX | Inhibrx Biosciences, Inc. - Common Stock | $1.6B | — | — |
| INCR | Intercure Ltd. - ordinary shares | $176.9M | — | — |
| INCY | Incyte Corporation - Common Stock | $19.4B | 16.3 | 2 |
| INDP | Indaptus Therapeutics, Inc. - Common Stock | $5.1M | — | — |
| INDV | Indivior Pharmaceuticals, Inc. - Common Stock | $4.5B | 35.8 | 1 |
| INGN | Inogen, Inc - Common Stock | $182.4M | — | — |
| INKT | MiNK Therapeutics, Inc. - Common Stock | $52.2M | — | — |
| INM | InMed Pharmaceuticals Inc. - Common Shares | $3.0M | — | — |
| INMB | INmune Bio Inc. - Common stock | $41.5M | — | — |
| INMD | InMode Ltd. - Ordinary Shares | $928.5M | 6.2 | 2 |
| INNV | InnovAge Holding Corp. - Common Stock | $704.2M | — | — |
| INO | Inovio Pharmaceuticals, Inc. - Common Stock | $109.4M | — | — |
| INSM | Insmed Incorporated - Common Stock | $23.3B | — | — |
| INSP | Inspire Medical Systems, Inc. Common Stock | $1.6B | 11.2 | — |
| INTS | Intensity Therapeutics, Inc. - Common Stock | $13.2M | — | — |
| INVA | Innoviva, Inc. - Common Stock | $1.7B | 3.3 | — |
| IONS | Ionis Pharmaceuticals, Inc. - Common Stock | $12.8B | — | — |
| IOVA | Iovance Biotherapeutics, Inc. - Common Stock | $1.8B | — | — |
| IPHA | Innate Pharma S.A. - American Depositary Shares | $147.7M | — | — |
| IPSC | Century Therapeutics, Inc. - Common Stock | $411.2M | — | — |
| IQV | IQVIA Holdings, Inc. Common Stock | $29.2B | 21.5 | — |
| IRD | Opus Genetics, Inc. - Common Stock | $390.7M | — | — |
| IRIX | IRIDEX Corporation - Common Stock | $18.1M | — | — |
| IRMD | iRadimed Corporation - Common Stock | $1.2B | 58.4 | 1 |
| IRON | Disc Medicine, Inc. - Common Stock | $2.6B | — | — |
| IRTC | iRhythm Holdings, Inc. - Common Stock | $5.7B | — | — |
| IRWD | Ironwood Pharmaceuticals, Inc. - Class A Common Stock | $548.2M | 19.2 | — |
| ISPC | iSpecimen Inc. - Common Stock | $2.5M | — | — |
| ISRG | Intuitive Surgical, Inc. - Common Stock | $200.8B | 73.1 | 4 |
| ITGR | Integer Holdings Corporation Common Stock | $3.0B | 29.6 | — |
| IVA | Inventiva S.A. - American Depository Shares | $753.5M | — | — |
| IVF | INVO Fertility, Inc. - Common Stock | $1.8M | — | — |
| IVVD | Invivyd, Inc. - Common Stock | $415.7M | — | — |
| IXHL | Incannex Healthcare Inc. - Common Stock | $55.3M | — | — |
| JAGX | Jaguar Health, Inc. - Common Stock | $1.5M | — | — |
| JANX | Janux Therapeutics, Inc. - Common Stock | $862.3M | — | — |
| JAZZ | Jazz Pharmaceuticals plc - Ordinary Shares | $10.3B | — | — |
| JBIO | Jade Biosciences, Inc. - Common Stock | $709.8M | — | — |
| JNJ | Johnson & Johnson Common Stock | $562.3B | 26.7 | — |
| JSPR | Jasper Therapeutics, Inc. - Class A Common Stock | $23.8M | — | — |
| JUNS | Jupiter Neurosciences, Inc. - Common Stock | $35.1M | — | — |
| JYNT | The Joint Corp. - Common Stock | $129.6M | — | — |
| KALA | KALA BIO, Inc. - Common Stock | $12.2M | — | — |
| KALV | KalVista Pharmaceuticals, Inc. - Common Stock | $1.4B | — | — |
| KEQU | Kewaunee Scientific Corporation - Common Stock | $114.6M | 10.3 | 2 |
| KIDS | OrthoPediatrics Corp. - Common Stock | $445.4M | — | — |
| KLRS | Kalaris Therapeutics, Inc. - Common Stock | $102.6M | — | — |
| KMDA | Kamada Ltd. - Ordinary Shares | $486.3M | 24.1 | 1 |
| KMTS | Kestra Medical Technologies, Ltd. - Common Stock | $1.5B | — | — |
| KNSA | Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | $3.1B | 87.0 | — |
| KOD | Kodiak Sciences Inc - Common Stock | $2.2B | — | — |
| KPRX | Kiora Pharmaceuticals, Inc. - Common Stock | $9.7M | — | — |
| KPTI | Karyopharm Therapeutics Inc. - Common Stock | $202.9M | — | — |
| KRMD | KORU Medical Systems, Inc. - Common Stock | $192.9M | — | — |
| KROS | Keros Therapeutics, Inc. - common stock | $207.8M | 2.4 | — |
| KRRO | Korro Bio, Inc. - Common Stock | $143.8M | — | — |
| KRYS | Krystal Biotech, Inc. - Common Stock | $7.1B | 35.9 | — |
| KTTA | Pasithea Therapeutics Corp. - Common Stock | $19.5M | — | — |
| KURA | Kura Oncology, Inc. - Common Stock | $904.1M | — | — |
| KYMR | Kymera Therapeutics, Inc. - Common Stock | $6.1B | — | — |
| KYTX | Kyverna Therapeutics, Inc. - Common Stock | $576.9M | — | — |
| KZIA | Kazia Therapeutics Limited - American Depositary Shares | $11.5M | — | — |
| LAB | Standard BioTools Inc. - Common Stock | $398.2M | 5.1 | — |
| LBRX | LB Pharmaceuticals Inc - Common Stock | $563.2M | — | — |
| LEGN | Legend Biotech Corporation - American Depositary Shares | $4.7B | — | — |
| LENZ | LENZ Therapeutics, Inc. - Common Stock | $313.2M | — | — |
| LEXX | Lexaria Bioscience Corp. - Common Stock | $15.4M | — | — |
| LFCR | Lifecore Biomedical, Inc. - Common Stock | $306.5M | — | — |
| LFMD | LifeMD, Inc. - Common Stock | $215.4M | 13.9 | — |
| LFMDP | LifeMD, Inc. - 8.875% Series A Cumulative Perpetual Preferred Stock | $164.1M | — | — |
| LFST | LifeStance Health Group, Inc. - Common Stock | $3.0B | 128.2 | — |
| LFWD | Lifeward Ltd. - Ordinary Shares | $10.1M | — | — |
| LGND | Ligand Pharmaceuticals Incorporated - Common Stock | $4.2B | 33.8 | — |
| LGVN | Longeveron Inc. - Class A Common stock | $17.6M | — | — |
| LH | Labcorp Holdings Inc. Common Stock | $21.9B | 25.0 | — |
| LIMN | Liminatus Pharma, Inc. - Class A Common Stock | $16.5M | — | — |
| LITS | Lite Strategy, Inc. - Common Stock | $48.6M | — | — |
| LIVN | LivaNova PLC - Ordinary Shares | $3.4B | — | — |
| LIXT | Lixte Biotechnology Holdings, Inc. - Common Stock | $31.5M | — | — |
| LLY | Eli Lilly and Company Common Stock | $869.2B | 42.1 | — |
| LMAT | LeMaitre Vascular, Inc. - Common Stock | $1.8B | 34.5 | 1 |
| LNAI | Lunai Bioworks Inc. - Common Stock | $20.7M | — | — |
| LNSR | LENSAR, Inc. - Common Stock | $138.9M | — | — |
| LNTH | Lantheus Holdings, Inc. - Common Stock | $4.4B | 26.3 | 2 |
| LPCN | Lipocine Inc. - Common Stock | $19.0M | — | — |
| LQDA | Liquidia Corporation - Common Stock | $3.7B | — | — |
| LRMR | Larimar Therapeutics, Inc. - Common Stock | $371.9M | — | — |
| LSTA | Lisata Therapeutics, Inc. - Common Stock | $16.4M | — | — |
| LTRN | Lantern Pharma Inc. - Common Stock | $35.5M | — | — |
| LUCD | Lucid Diagnostics Inc. - Common Stock | $180.8M | — | — |
| LUCY | Innovative Eyewear, Inc. - Common Stock | $5.9M | — | — |
| LUNG | Pulmonx Corporation - Common Stock | $91.2M | — | — |
| LXEO | Lexeo Therapeutics, Inc. - Common Stock | $399.7M | — | — |
| LXRX | Lexicon Pharmaceuticals, Inc. - Common Stock | $847.4M | — | — |
| LYEL | Lyell Immunopharma, Inc. - Common Stock | $451.0M | — | — |
| MANE | Veradermics, Incorporated Common Stock | $2.6B | — | — |
| MASI | Masimo Corporation - Common Stock | $7.0B | — | — |
| MAZE | Maze Therapeutics, Inc. - Common Stock | $1.4B | — | — |
| MBAI | Check-Cap Ltd. - Ordinary Share | $13.9M | — | — |
| MBIO | Mustang Bio, Inc. - Common Stock | $7.2M | — | — |
| MBOT | Microbot Medical Inc. - Common Stock | $124.3M | — | — |
| MBRX | Moleculin Biotech, Inc. - Common Stock | $11.3M | — | — |
| MBX | MBX Biosciences, Inc. - Common Stock | $1.5B | — | — |
| MCK | McKesson Corporation Common Stock | $106.6B | 24.6 | — |
| MCRB | Seres Therapeutics, Inc. - Common Stock | $134.6M | 25.0 | — |
| MD | Pediatrix Medical Group, Inc. Common Stock | $1.8B | 11.1 | — |
| MDAI | Spectral AI, Inc. - Class A Common Stock | $74.1M | — | — |
| MDCX | Medicus Pharma Ltd. - Common Stock | $16.6M | — | — |
| MDGL | Madrigal Pharmaceuticals, Inc. - Common Stock | $11.8B | — | — |
| MDT | Medtronic plc. Ordinary Shares | $110.9B | 24.0 | — |
| MDWD | MediWound Ltd. - Ordinary Shares | $236.7M | — | — |
| MDXG | MiMedx Group, Inc - Common Stock | $1.0B | 24.6 | 2 |
| MDXH | MDxHealth SA - Ordinary Shares | $100.2M | — | — |
| MEDP | Medpace Holdings, Inc. - Common Stock | $15.8B | 36.5 | 1 |
| MENS | Jyong Biotech Ltd. - Ordinary shares | $300.3M | — | — |
| MESO | Mesoblast Limited - American Depositary Shares | $3.5B | — | — |
| MGNX | MacroGenics, Inc. - Common Stock | $210.4M | — | — |
| MGTX | MeiraGTx Holdings plc - Ordinary Shares | $870.0M | — | — |
| MGX | Metagenomi Therapeutics, Inc. - Common Stock | $49.3M | — | — |
| MIRA | MIRA Pharmaceuticals, Inc. - Common Stock | $63.2M | — | — |
| MIRM | Mirum Pharmaceuticals, Inc. - common stock | $4.1B | — | — |
| MIST | Milestone Pharmaceuticals Inc. - Common Shares | $223.6M | — | — |
| MLAB | Mesa Laboratories, Inc. - Common Stock | $433.5M | — | — |
| MLTX | MoonLake Immunotherapeutics - Class A Ordinary Shares | $1.2B | — | — |
| MLYS | Mineralys Therapeutics, Inc. - Common Stock | $2.3B | — | 1 |
| MMSI | Merit Medical Systems, Inc. - Common Stock | $5.2B | 44.1 | 1 |
| MNDR | Mobile-health Network Solutions - Class A Ordinary Shares | $1.1M | — | — |
| MNKD | MannKind Corporation - Common Stock | $1.1B | 157.3 | 1 |
| MNOV | MediciNova, Inc. - Common Stock | $67.9M | — | — |
| MNPR | Monopar Therapeutics Inc. - Common Stock | $396.6M | — | — |
| MODD | Modular Medical, Inc. - common stock | $27.6M | — | — |
| MOH | Molina Healthcare Inc Common Stock | $7.7B | 16.4 | — |
| MOLN | Molecular Partners AG - American Depositary Shares | $136.7M | — | — |
| MPLT | MapLight Therapeutics, Inc. - Common Stock | $1.2B | — | — |
| MREO | Mereo BioPharma Group plc - American Depositary Shares | $38.6M | — | — |
| MRK | Merck & Company, Inc. Common Stock (new) | $291.9B | 16.0 | — |
| MRKR | Marker Therapeutics, Inc. - Common Stock | $23.7M | — | — |
| MRNA | Moderna, Inc. - Common Stock | $11.5B | — | — |
| MRVI | Maravai LifeSciences Holdings, Inc. - Class A common stock | $1.2B | — | — |
| MTD | Mettler-Toledo International, Inc. Common Stock | $26.2B | 30.1 | — |
| MTVA | MetaVia Inc. - Common Stock | $5.7M | — | — |
| MXCT | MaxCyte, Inc. - Common Stock | $90.8M | — | — |
| MYGN | Myriad Genetics, Inc. - Common Stock | $573.3M | — | — |
| NAGE | Niagen Bioscience, Inc. - Common Stock | $308.6M | 16.6 | — |
| NAKA | Nakamoto Inc. - Common Stock | $154.4M | — | — |
| NAMS | NewAmsterdam Pharma Company N.V. - Ordinary Shares | $3.6B | — | — |
| NAUT | Nautilus Biotechnology, Inc. - Common Stock | $246.3M | — | — |
| NBIX | Neurocrine Biosciences, Inc. - Common Stock | $14.1B | 33.0 | 4 |
| NBP | NovaBridge Biosciences - American Depositary Shares | $458.9M | — | — |
| NBTX | Nanobiotix S.A. - ADSs | $943.5M | — | — |
| NCEL | NewcelX Ltd. - Ordinary Shares | $8.7M | — | — |
| NCNA | NuCana plc - American Depositary Shares | $14.7M | — | — |
| NDRA | ENDRA Life Sciences Inc. - Common Stock | $6.3M | — | — |
| NEO | NeoGenomics, Inc. - Common Stock | $1.5B | — | — |
| NEOG | Neogen Corporation - Common Stock | $1.5B | — | — |
| NERV | Minerva Neurosciences, Inc - Common Stock | $272.5M | — | — |
| NEUP | Neuphoria Therapeutics Inc. - Common Stock | $25.5M | — | — |
| NGNE | Neurogene Inc. - Common Stock | $471.2M | — | — |
| NIVF | NewGenIvf Group Limited - Class A Ordinary Shares | $909K | 0.1 | — |
| NKTR | Nektar Therapeutics - Common Stock | $2.7B | — | — |
| NKTX | Nkarta, Inc. - Common Stock | $226.7M | — | — |
| NMRA | Neumora Therapeutics, Inc. - Common Stock | $340.9M | — | — |
| NMTC | NeuroOne Medical Technologies Corporation - Common Stock | $38.2M | — | — |
| NNNN | Anbio Biotechnology - Class A Ordinary Shares | $4.3B | 724.8 | — |
| NNOX | NANO-X IMAGING LTD - Ordinary Shares | $178.5M | — | — |
| NOTV | Inotiv, Inc. - Common Stock | $19.3M | — | — |
| NPCE | Neuropace, Inc. - Common Stock | $532.0M | — | — |
| NRC | National Research Corporation - Common Stock | $425.3M | 26.0 | — |
| NRIX | Nurix Therapeutics, Inc. - Common stock | $1.9B | — | — |
| NRSN | NeuroSense Therapeutics Ltd. - Ordinary Shares | $22.8M | — | — |
| NRXP | NRX Pharmaceuticals, Inc. - Common Stock | $108.5M | — | — |
| NSPR | InspireMD Inc. - Common Stock | $56.2M | — | — |
| NTHI | NeOnc Technologies Holdings, Inc. - Common Stock | $139.1M | — | — |
| NTLA | Intellia Therapeutics, Inc. - Common Stock | $1.0B | — | — |
| NTRA | Natera, Inc. - Common Stock | $27.6B | — | — |
| NTRB | Nutriband Inc. - Common Stock | $55.3M | — | — |
| NUTX | Nutex Health Inc. - Common Stock | $940.4M | 14.6 | — |
| NUVB | Nuvation Bio Inc. Class A Common Stock | $1.5B | — | — |
| NUVL | Nuvalent, Inc. - Class A Common Stock | $8.0B | — | — |
| NUWE | Nuwellis, Inc. - Common Stock | $2.4M | — | — |
| NVAX | Novavax, Inc. - Common Stock | $1.6B | — | — |
| NVCR | NovoCure Limited - Ordinary Shares | $1.4B | — | — |
| NVCT | Nuvectis Pharma, Inc. - Common Stock | $309.0M | — | — |
| NVNO | enVVeno Medical Corporation - Common Stock | $6.5M | — | — |
| NVO | Novo Nordisk A/S Common Stock | $1.1T | 10.9 | — |
| NVS | Novartis AG Common Stock | $216.0B | 19.7 | — |
| NVST | Envista Holdings Corporation Common Stock | $4.4B | 93.9 | — |
| NXGL | NexGel, Inc - Common Stock | $5.8M | — | — |
| NXL | Nexalin Technology, Inc. - Common Stock | $7.0M | — | — |
| NXTC | NextCure, Inc. - Common Stock | $49.7M | — | — |
| NYXH | Nyxoah SA - Ordinary Shares | $175.8M | — | — |
| OABI | OmniAb, Inc. - Common Stock | $207.0M | — | — |
| OBIO | Orchestra BioMed Holdings, Inc. - Ordinary Shares | $222.8M | — | — |
| OCGN | Ocugen, Inc. - Common Stock | $492.5M | — | — |
| OCS | Oculis Holding AG - Ordinary shares | $1.9B | — | — |
| OCUL | Ocular Therapeutix, Inc. - Common Stock | $2.1B | — | — |
| ODYS | Odysight.ai Inc. - Common Stock | $74.6M | — | — |
| OFIX | Orthofix Medical Inc. - Common Stock | $600.3M | — | — |
| OGI | Organigram Global Inc. - Common Shares | $311.9M | — | — |
| OGN | Organon & Co. Common Stock | $2.4B | 13.0 | — |
| OKUR | OnKure Therapeutics, Inc. - Class A Common Stock | $157.9M | — | — |
| OKYO | OKYO Pharma Limited - Ordinary Shares | $77.9M | — | — |
| OLMA | Olema Pharmaceuticals, Inc. - Common Stock | $1.3B | — | — |
| OM | Outset Medical, Inc. - Common Stock | $67.3M | — | — |
| OMCL | Omnicell, Inc. - Common Stock | $2.0B | 98.3 | — |
| OMDA | Omada Health, Inc. - Common Stock | $886.4M | — | — |
| OMER | Omeros Corporation - Common Stock | $1.0B | — | — |
| ONC | BeOne Medicines Ltd. - American Depositary Shares | $261.0B | — | — |
| ONCO | Onconetix, Inc. - Common Stock | $2.4M | — | — |
| ONCY | Oncolytics Biotech Inc. - Common Shares | $142.7M | — | — |
| ONMD | OneMedNet Corp - Class A Common Stock | $56.1M | — | — |
| OPCH | Option Care Health, Inc. - Common Stock | $5.1B | 24.2 | 4 |
| OPK | Opko Health, Inc. - Common Stock | $849.5M | — | — |
| OPRX | OptimizeRx Corporation - Common Stock | $119.0M | 23.2 | — |
| ORGO | Organogenesis Holdings Inc. - Class A | $325.5M | 8.8 | — |
| ORIC | Oric Pharmaceuticals, Inc. - Common Stock | $796.6M | — | — |
| ORKA | Oruka Therapeutics, Inc. - Common Stock | $3.5B | — | — |
| ORMP | Oramed Pharmaceuticals Inc. - Common Stock | $113.4M | 2.6 | — |
| OSRH | OSR Holdings, Inc. - Common Stock | $14.5M | — | — |
| OSUR | OraSure Technologies, Inc. - Common Stock | $201.7M | — | — |
| OTLK | Outlook Therapeutics, Inc. - Common Stock | $27.5M | — | — |
| OVID | Ovid Therapeutics Inc. - Common Stock | $451.7M | — | — |
| OWLT | Owlet, Inc. Class A Common Stock | $154.3M | — | — |
| PACB | Pacific Biosciences of California, Inc. - Common Stock | $564.6M | — | — |
| PACS | PACS Group, Inc. Common Stock | $5.9B | 31.0 | — |
| PAHC | Phibro Animal Health Corporation - Class A Common Stock | $1.5B | 22.4 | — |
| PALI | Palisade Bio, Inc. - Common Stock | $317.7M | — | — |
| PARK | Park Dental Partners, Inc. - Common Stock | $81.9M | — | — |
| PASG | Passage Bio, Inc. - Common Stock | $16.1M | — | — |
| PAVM | PAVmed Inc. - Common Stock | $41.7M | 103.9 | — |
| PBH | Prestige Consumer Healthcare Inc. Common Stock | $2.7B | 14.5 | — |
| PBM | Psyence Biomedical Ltd. - Common Shares | $1.4M | 5.5 | — |
| PBYI | Puma Biotechnology Inc - Common Stock | $299.8M | 8.1 | — |
| PCRX | Pacira BioSciences, Inc. - Common Stock | $975.1M | 189.8 | — |
| PCSA | Processa Pharmaceuticals, Inc. - Common Stock | $6.5M | — | — |
| PCVX | Vaxcyte, Inc. - Common Stock | $6.0B | — | 1 |
| PDEX | Pro-Dex, Inc. - Common Stock | $125.5M | 11.2 | 1 |
| PDSB | PDS Biotechnology Corporation - Common Stock | $61.4M | — | — |
| PEN | Penumbra, Inc. Common Stock | $13.0B | 73.4 | — |
| PEPG | PepGen Inc. - Common Stock | $107.2M | — | — |
| PFE | Pfizer, Inc. Common Stock | $154.8B | 19.9 | — |
| PFSA | Profusa, Inc. - Common Stock | $6.9M | — | — |
| PGEN | Precigen, Inc. - Common Stock | $1.5B | — | — |
| PGNY | Progyny, Inc. - Common Stock | $1.5B | 25.0 | 1 |
| PHAR | Pharming Group N.V. - ADS, each representing 10 ordinary shares | $977.0M | 11475.5 | — |
| PHAT | Phathom Pharmaceuticals, Inc. - Common Stock | $969.8M | — | — |
| PHG | Koninklijke Philips N.V. NY Registry Shares | $23.5B | 26.3 | — |
| PHIO | Phio Pharmaceuticals Corp. - Common Stock | $12.8M | — | — |
| PHR | Phreesia, Inc. Common Stock | $557.2M | 241.6 | — |
| PHVS | Pharvaris N.V. - Ordinary Shares | $2.0B | — | — |
| PIII | P3 Health Partners Inc. - Class A Common Stock | $25.8M | — | — |
| PLRX | Pliant Therapeutics, Inc. - Common Stock | $71.2M | — | — |
| PLRZ | Polyrizon Ltd. - Ordinary Shares | $13.5M | — | — |
| PLSE | Pulse Biosciences, Inc - Common Stock | $1.3B | — | — |
| PLUR | Pluri Inc. - Common Stock | $27.7M | — | — |
| PMCB | PharmaCyte Biotech, Inc. - Common Stock | $7.3M | — | — |
| PMN | ProMIS Neurosciences Inc. - Common Shares | $22.6M | — | — |
| PMVP | PMV Pharmaceuticals, Inc. - Common Stock | $74.1M | — | — |
| PNTG | The Pennant Group, Inc. - Common Stock | $973.8M | 36.5 | — |
| POCI | Precision Optics Corporation, Inc. - Common stock | $49.1M | — | — |
| PODD | Insulet Corporation - Common Stock | $20.0B | 81.2 | — |
| POM | POMDOCTOR LIMITED - American Depositary Shares | $37.6M | — | — |
| PPBT | Purple Biotech Ltd. - American Depositary Shares | $22.3M | — | — |
| PPCB | Propanc Biopharma, Inc. - Common Stock | $7.2M | — | — |
| PRAX | Praxis Precision Medicines, Inc. - Common Stock | $9.3B | — | — |
| PRCT | PROCEPT BioRobotics Corporation - Common Stock | $1.8B | — | — |
| PRE | Prenetics Global Limited - Class A Ordinary Share | $222.2M | — | — |
| PRFX | PRF Technologies Ltd. - Ordinary Shares | $2.5M | — | — |
| PRGO | Perrigo Company plc Ordinary Shares | $1.6B | — | — |
| PRLD | Prelude Therapeutics Incorporated - Common Stock | $302.4M | — | — |
| PRME | Prime Medicine, Inc. - Common Stock | $612.1M | — | — |
| PROF | Profound Medical Corp. - common stock | $325.2M | — | — |
| PROK | ProKidney Corp. - Class A Ordinary Shares | $501.3M | — | — |
| PRPO | Precipio, Inc. - Common Stock | $40.3M | — | — |
| PRQR | ProQR Therapeutics N.V. - Ordinary Shares | $212.5M | — | — |
| PRTA | Prothena Corporation plc - Ordinary Shares | $508.3M | — | — |
| PRVA | Privia Health Group, Inc. - Common Stock | $2.9B | 160.5 | — |
| PSNL | Personalis, Inc. - Common Stock | $706.9M | — | — |
| PSTV | PLUS THERAPEUTICS, Inc. - Common Stock | $36.0M | — | — |
| PTCT | PTC Therapeutics, Inc. - Common Stock | $6.1B | 8.1 | 1 |
| PTGX | Protagonist Therapeutics, Inc. - Common Stock | $5.5B | 118.9 | 1 |
| PULM | Pulmatrix, Inc. - Common Stock | $8.1M | — | — |
| PURR | Hyperliquid Strategies Inc - Common Stock | — | — | — |
| PVLA | Palvella Therapeutics, Inc. - Common Stock | $1.7B | — | — |
| PYPD | PolyPid Ltd. - Ordinary Shares | $87.0M | — | — |
| PYXS | Pyxis Oncology, Inc. - Common Stock | $143.3M | — | — |
| QCLS | Q/C Technologies, Inc. - Common Stock | $16.6M | — | — |
| QDEL | QuidelOrtho Corporation - Common Stock | $1.9B | — | — |
| QGEN | Qiagen N.V. Common Shares | $8.4B | 19.9 | — |
| QNCX | Quince Therapeutics, Inc. - Common Stock | $20.2M | — | — |
| QNRX | Quoin Pharmaceuticals, Ltd. - American Depositary Shares | $9.5M | — | — |
| QNTM | Quantum Biopharma Ltd. - Class B Subordinate Voting Shares | $40.4M | — | — |
| QSI | Quantum-Si Incorporated - Class A Common Stock | $199.5M | — | — |
| QTRX | Quanterix Corporation - Common Stock | $133.1M | — | — |
| QTTB | Q32 Bio Inc. - Common Stock | $91.1M | 3.1 | — |
| QURE | uniQure N.V. - Ordinary Shares | $1.7B | — | — |
| RADX | Radiopharm Theranostics Limited - American Depositary Shares | $88.6M | — | — |
| RANI | Rani Therapeutics Holdings, Inc. - Class A Common Stock | $133.7M | — | — |
| RAPP | Rapport Therapeutics, Inc. - Common Stock | $1.7B | — | — |
| RARE | Ultragenyx Pharmaceutical Inc. - Common Stock | $2.2B | — | — |
| RCEL | Avita Medical, Inc. - Common Stock | $134.2M | — | — |
| RCKT | Rocket Pharmaceuticals, Inc. - Common Stock | $379.9M | — | — |
| RCUS | Arcus Biosciences, Inc. Common Stock | $3.1B | — | — |
| RDHL | Redhill Biopharma Ltd. - American Depositary Shares | $4.7M | — | — |
| RDNT | RadNet, Inc. - Common Stock | $4.6B | — | 1 |
| RDY | Dr. Reddy's Laboratories Ltd Common Stock | $1.0T | 18.3 | — |
| REGN | Regeneron Pharmaceuticals, Inc. - Common Stock | $81.1B | 17.7 | 1 |
| REPL | Replimune Group, Inc. - Common Stock | $762.5M | — | — |
| REVB | Revelation Biosciences, Inc. - Common Stock | $3.6M | — | — |
| RFL | Rafael Holdings, Inc. Class B Common Stock | $63.5M | — | — |
| RGC | Regencell Bioscience Holdings Limited - Ordinary Shares | $10.4B | — | — |
| RGEN | Repligen Corporation - Common Stock | $9.2B | 5307.1 | — |
| RGNX | REGENXBIO Inc. - Common Stock | $514.1M | — | — |
| RIGL | Rigel Pharmaceuticals, Inc. - Common Stock | $777.4M | 6.9 | — |
| RLAY | Relay Therapeutics, Inc. - Common Stock | $1.5B | — | — |
| RLMD | Relmada Therapeutics, Inc. - Common Stock | $781.4M | — | — |
| RLYB | Rallybio Corporation - Common Stock | $75.8M | — | — |
| RMD | ResMed Inc. Common Stock | $32.7B | 22.0 | — |
| RMTI | Rockwell Medical, Inc. - Common Stock | $33.4M | — | — |
| RNA | Avidity Biosciences, Inc. - Common Stock | $226.4M | — | — |
| RNAC | Cartesian Therapeutics, Inc. - Common Stock | $245.5M | — | — |
| RNAZ | TransCode Therapeutics, Inc. - Common Stock | $6.3M | — | — |
| RNTX | Rein Therapeutics, Inc. - Common Stock | $29.4M | — | — |
| RNXT | RenovoRx, Inc. - Common Stock | $38.2M | — | — |
| ROIV | Roivant Sciences Ltd. - Common Shares | $15.1B | — | — |
| RPID | Rapid Micro Biosystems, Inc. - Class A Common Stock | $113.5M | — | — |
| RPRX | Royalty Pharma plc - Class A Ordinary Shares | $22.3B | 29.2 | — |
| RVMD | Revolution Medicines, Inc. - Common Stock | $30.1B | — | — |
| RVTY | Revvity, Inc. Common Stock | $10.0B | 41.5 | — |
| RXRX | Recursion Pharmaceuticals, Inc. - Class A Common Stock | $2.1B | — | — |
| RXST | RxSight, Inc. - Common Stock | $242.2M | — | — |
| RYOJ | rYojbaba Co., Ltd. - Common Shares | $34.3M | 19.3 | — |
| RYTM | Rhythm Pharmaceuticals, Inc. - Common Stock | $7.1B | — | — |
| RZLT | Rezolute, Inc. - Common Stock (NV) | $218.8M | — | — |
| SABS | SAB Biotherapeutics, Inc. - Common Stock | $189.5M | 14.3 | — |
| SANA | Sana Biotechnology, Inc. - Common Stock | $854.4M | — | — |
| SBC | SBC Medical Group Holdings Incorporated - Common Stock | $331.3M | 6.5 | — |
| SBFM | Sunshine Biopharma Inc. - Common stock | $3.2M | — | — |
| SCLX | Scilex Holding Company - Common Stock | $51.0M | — | — |
| SCNI | Scinai Immunotherapeutics Ltd. - American Depositary Shares | $612K | 0.1 | — |
| SCNX | Scienture Holdings, Inc. - Common Stock | $16.4M | — | — |
| SCYX | SCYNEXIS, Inc. - Common Stock | $58.8M | — | — |
| SDGR | Schrodinger, Inc. - Common Stock | $1.3B | — | — |
| SEER | Seer, Inc. - Class A Common Stock | $99.9M | — | — |
| SEM | Select Medical Holdings Corporation Common Stock | $2.0B | 13.9 | — |
| SENS | Senseonics Holdings, Inc. - Common Stock | $262.5M | — | — |
| SEPN | Septerna, Inc. - Common Stock | $1.2B | — | — |
| SERA | Sera Prognostics, Inc. - Class A Common Stock | $67.7M | — | — |
| SGHT | Sight Sciences, Inc. - Common Stock | $288.9M | — | — |
| SGMT | Sagimet Biosciences Inc. - Series A Common Stock | $407.5M | — | — |
| SGRY | Surgery Partners, Inc. - Common Stock | $1.9B | — | — |
| SHC | Sotera Health Company - Common Stock | $5.0B | 90.4 | — |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. - common stock | $2.9M | — | — |
| SI | Shoulder Innovations, Inc. Common Stock | $279.4M | — | — |
| SIBN | SI-BONE, Inc. - Common Stock | $855.7M | — | — |
| SIGA | SIGA Technologies Inc. - Common Stock | $437.5M | 5.9 | — |
| SILO | Silo Pharma, Inc. - Common Stock | $4.5M | — | — |
| SINT | SiNtx Technologies, Inc. - Common Stock | $9.3M | — | — |
| SION | Sionna Therapeutics, Inc. - Common Stock | $1.8B | — | — |
| SKYE | Skye Bioscience, Inc. - Common Stock | $28.6M | — | — |
| SLDB | Solid Biosciences Inc. - Common Stock | $751.7M | — | — |
| SLGL | Sol-Gel Technologies Ltd. - Ordinary Shares | $117.4M | — | — |
| SLN | Silence Therapeutics Plc - American Depository Share | $287.2M | — | — |
| SLP | Simulations Plus, Inc. - Common Stock | $367.3M | — | — |
| SLS | SELLAS Life Sciences Group, Inc. - Common Stock | $1.3B | — | — |
| SLXN | Silexion Therapeutics Corp - Ordinary Shares | $1.2M | — | — |
| SMMT | Summit Therapeutics Inc. - Common Stock | $13.6B | — | — |
| SMTI | Sanara MedTech Inc. - Common Stock | $193.0M | — | — |
| SNDA | Sonida Senior Living, Inc. Common Stock | $1.8B | — | — |
| SNDL | SNDL Inc. - Common Shares | $370.7M | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. - Common Stock | $1.9B | — | — |
| SNES | SenesTech, Inc. - Common Stock | $8.8M | — | — |
| SNGX | Soligenix, Inc. - Common Stock | $5.3M | — | — |
| SNN | Smith & Nephew SNATS, Inc. Common Stock | $10.8B | 23.3 | — |
| SNOA | Sonoma Pharmaceuticals, Inc. - Common Stock | $6.2M | — | — |
| SNSE | Sensei Biotherapeutics, Inc. - Common Stock | $27.4M | — | — |
| SNTI | Senti Biosciences, Inc. - Common Stock | $31.5M | — | — |
| SNWV | SANUWAVE Health, Inc. - Common Stock | $144.9M | 12.3 | — |
| SNY | Sanofi - American Depositary Shares | $100.2B | 7.2 | 2 |
| SOLV | Solventum Corporation Common Stock | $11.9B | 7.7 | — |
| SOPH | SOPHiA GENETICS SA - Ordinary Shares | $369.1M | — | — |
| SPRB | Spruce Biosciences, Inc. - Common Stock | $93.2M | — | — |
| SPRC | SciSparc Ltd. - Ordinary Shares | $4.5M | — | — |
| SPRO | Spero Therapeutics, Inc. - Common Stock | $141.5M | 16.5 | — |
| SPRY | ARS Pharmaceuticals, Inc. - Common Stock | $795.4M | — | — |
| SRPT | Sarepta Therapeutics, Inc. - Common Stock | $2.3B | — | — |
| SRRK | Scholar Rock Holding Corporation - Common Stock | $5.8B | — | — |
| SRTS | Sensus Healthcare, Inc. - Common Stock | $56.1M | — | — |
| SRZN | Surrozen, Inc. - Common Stock | $326.8M | — | — |
| SSII | SS Innovations International Inc. - Common Stock | $1.1B | — | — |
| STAA | STAAR Surgical Company - Common Stock | $1.4B | — | — |
| STE | STERIS plc (Ireland) Ordinary Shares | $21.6B | 30.5 | — |
| STEX | Streamex Corp. - Common Stock | $93.7M | — | — |
| STIM | Neuronetics, Inc. - Common Stock | $104.7M | — | — |
| STOK | Stoke Therapeutics, Inc. - Common Stock | $2.0B | — | 1 |
| STRO | Sutro Biopharma, Inc. - Common Stock | $645.7M | — | — |
| STSS | Sharps Technology Inc. - Common Stock | $58.9M | — | — |
| STTK | Shattuck Labs, Inc. - Common Stock | $538.3M | — | — |
| STVN | Stevanato Group S.p.A. Ordinary Shares | $3.7B | 22.5 | — |
| SUPN | Supernus Pharmaceuticals, Inc. - Common Stock | $3.0B | — | — |
| SVA | Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) | $639.9M | — | — |
| SVRA | Savara, Inc. - Common Stock | $1.0B | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. - Common Stock | $185.6M | — | — |
| SXTP | 60 Degrees Pharmaceuticals, Inc. - Common Stock | $3.7M | — | — |
| SYK | Stryker Corporation Common Stock | $129.3B | 39.8 | — |
| SYRE | Spyre Therapeutics, Inc. - Common Stock | $6.5B | — | — |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | $9.0T | 79.4 | — |
| TALK | Talkspace, Inc. - Common Stock | $601.3M | 141.8 | — |
| TARA | Protara Therapeutics, Inc. - Common Stock | $275.2M | — | — |
| TARS | Tarsus Pharmaceuticals, Inc. - Common Stock | $2.6B | — | — |
| TBPH | Theravance Biopharma, Inc. - Ordinary Shares | $867.1M | 7.6 | — |
| TBRG | TruBridge, Inc. - Common Stock | $387.9M | 89.1 | — |
| TCMD | Tactile Systems Technology, Inc. - Common Stock | $578.6M | 30.3 | — |
| TCRT | Alaunos Therapeutics, Inc. - Common Stock | $7.2M | — | — |
| TCRX | TScan Therapeutics, Inc. - Common Stock | $75.7M | — | — |
| TDOC | Teladoc Health, Inc. Common Stock | $909.8M | — | — |
| TECH | Bio-Techne Corp - Common Stock | $9.2B | 119.2 | — |
| TECX | Tectonic Therapeutic, Inc. - Common Stock | $390.4M | — | — |
| TELA | TELA Bio, Inc. - Common stock | $45.6M | — | — |
| TELO | Telomir Pharmaceuticals, Inc. - Common Stock | $45.7M | — | — |
| TEM | Tempus AI, Inc. - Class A Common Stock | $8.9B | — | — |
| TENX | Tenax Therapeutics, Inc. - Common Stock | $202.8M | — | — |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | $108.9B | 25.4 | — |
| TFX | Teleflex Incorporated Common Stock | $5.7B | — | — |
| TGTX | TG Therapeutics, Inc. - Common Stock | $6.6B | 14.7 | 1 |
| THC | Tenet Healthcare Corporation Common Stock | $16.7B | 11.9 | — |
| TIL | Instil Bio, Inc. - Common Stock | $54.7M | — | — |
| TKNO | Alpha Teknova, Inc. - Common Stock | $204.3M | — | — |
| TLPH | Talphera, Inc. - Common Stock | $42.9M | — | — |
| TLRY | Tilray Brands, Inc. - Common Stock | $1.0B | — | — |
| TLSA | Tiziana Life Sciences Ltd - Common Shares | $177.1M | — | — |
| TLSI | TriSalus Life Sciences, Inc. - Common Stock | $278.8M | — | — |
| TMCI | Treace Medical Concepts, Inc. - Common Stock | $125.7M | — | — |
| TMDX | TransMedics Group, Inc. - Common Stock | $3.3B | 17.2 | 2 |
| TMO | Thermo Fisher Scientific Inc Common Stock | $193.3B | 28.9 | — |
| TNDM | Tandem Diabetes Care, Inc. - Common Stock | $1.3B | — | — |
| TNGX | Tango Therapeutics, Inc. - Common Stock | $3.7B | — | — |
| TNON | Tenon Medical, Inc. - Common Stock | $8.0M | — | — |
| TNXP | Tonix Pharmaceuticals Holding Corp. - Common Stock | $199.0M | — | — |
| TNYA | Tenaya Therapeutics, Inc. - Common Stock | $216.6M | — | — |
| TOI | The Oncology Institute, Inc. - Common Stock | $400.9M | — | — |
| TPST | Tempest Therapeutics, Inc. - Common Stock | $26.2M | — | — |
| TRAW | Traws Pharma, Inc. - Common Stock | $24.2M | 2.6 | — |
| TRDA | Entrada Therapeutics, Inc. - Common Stock | $392.9M | — | — |
| TRIB | Trinity Biotech plc - American Depositary Shares | $15.3M | — | — |
| TRVI | Trevi Therapeutics, Inc. - Common Stock | $1.6B | — | — |
| TSHA | Taysha Gene Therapies, Inc. - Common Stock | $1.6B | — | — |
| TTRX | Turn Therapeutics Inc. - Common Stock | — | — | — |
| TVGN | Tevogen Bio Holdings Inc. - Common Stock | $65.8M | — | — |
| TVRD | Tvardi Therapeutics, Inc. - Common Stock | $37.5M | — | — |
| TVTX | Travere Therapeutics, Inc. - Common Stock | $3.4B | — | — |
| TWST | Twist Bioscience Corporation - Common Stock | $1.9B | — | — |
| TXG | 10x Genomics, Inc. - Common Stock | $2.9B | — | — |
| TXMD | TherapeuticsMD, Inc. - Common Stock | $18.9M | 62.5 | — |
| TYRA | Tyra Biosciences, Inc. - Common Stock | $1.4B | — | — |
| UFPT | UFP Technologies, Inc. - Common Stock | $1.7B | 25.5 | 1 |
| UHS | Universal Health Services, Inc. Common Stock | $11.0B | 7.4 | — |
| UNCY | Unicycive Therapeutics, Inc. - Common Stock | $224.7M | — | — |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | $287.7B | 23.9 | — |
| UPB | Upstream Bio, Inc. - Common Stock | $478.4M | — | — |
| UPC | Universe Pharmaceuticals Inc - Class A Ordinary Shares | $2.1M | 2.0 | — |
| URGN | UroGen Pharma Ltd. - Ordinary Shares | $1.4B | — | — |
| USPH | U.S. Physical Therapy, Inc. Common Stock | $1.2B | 29.5 | — |
| UTHR | United Therapeutics Corporation - Common Stock | $21.0B | 16.5 | — |
| UTMD | Utah Medical Products, Inc. - Common Stock | $179.3M | 15.4 | — |
| VALN | Valneva SE - American Depositary Shares | $639.8M | — | — |
| VANI | Vivani Medical, Inc. - Common Stock | $94.1M | — | — |
| VCEL | Vericel Corporation - Common Stock | $1.7B | 101.6 | — |
| VCYT | Veracyte, Inc. - Common Stock | $3.2B | 36.4 | — |
| VEEV | Veeva Systems Inc. Class A Common Stock | $27.4B | 30.1 | — |
| VERA | Vera Therapeutics, Inc. - Class A Common Stock | $3.5B | — | — |
| VERU | Veru Inc. - Common Stock | $34.3M | — | — |
| VIR | Vir Biotechnology, Inc. - Common Stock | $838.9M | — | — |
| VIVS | VivoSim Labs, Inc. - Common Stock | $4.7M | — | — |
| VKTX | Viking Therapeutics, Inc. - Common Stock | $4.0B | — | 1 |
| VMD | Viemed Healthcare, Inc. - Common Shares | $282.5M | 20.8 | 1 |
| VNDA | Vanda Pharmaceuticals Inc. - Common Stock | $521.2M | — | — |
| VOR | Vor Biopharma Inc. - Common Stock | $816.7M | — | — |
| VRAX | Virax Biolabs Group Limited - Ordinary Shares | $1.5M | — | — |
| VRCA | Verrica Pharmaceuticals Inc. - Common Stock | $125.7M | — | — |
| VRDN | Viridian Therapeutics, Inc. - Common Stock | $1.8B | — | — |
| VREX | Varex Imaging Corporation - Common Stock | $485.8M | — | — |
| VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | $115.0B | 31.3 | 4 |
| VSEE | VSee Health, Inc. - Common Stock | $12.4M | — | — |
| VSTM | Verastem, Inc. - Common Stock | $425.3M | — | — |
| VTGN | Vistagen Therapeutics, Inc. - Common Stock | $26.1M | — | — |
| VTRS | Viatris Inc. - Common Stock | $18.1B | — | — |
| VTVT | vTv Therapeutics Inc. - Class A Common Stock | $124.7M | — | — |
| VVOS | Vivos Therapeutics, Inc. - Common Stock | $18.2M | — | — |
| VYGR | Voyager Therapeutics, Inc. - Common Stock | $228.4M | — | — |
| VYNE | VYNE Therapeutics Inc. - Common Stock | $22.3M | — | — |
| WAT | Waters Corporation Common Stock | $34.8B | 54.2 | — |
| WAY | Waystar Holding Corp. - Common Stock | $6.3B | 56.4 | 1 |
| WGRX | Wellgistics Health, Inc. - Common Stock | $22.0M | — | — |
| WGS | GeneDx Holdings Corp. - Class A Common Stock | $3.8B | 1803.0 | — |
| WHWK | Whitehawk Therapeutics, Inc. - Common Stock | $114.1M | — | — |
| WOK | WORK Medical Technology Group LTD - Class A Ordinary Shares | $186K | 14.2 | — |
| WST | West Pharmaceutical Services, Inc. Common Stock | $19.1B | 38.8 | — |
| WVE | Wave Life Sciences Ltd. - Ordinary Shares | $1.4B | — | — |
| XAIR | Beyond Air, Inc. - Common Stock | $5.8M | — | — |
| XBIO | Xenetic Biosciences, Inc. - Common Stock | $5.0M | — | — |
| XBIT | XBiotech Inc. - Common Stock | $72.9M | — | — |
| XCUR | Exicure, Inc. - Common Stock | $34.5M | — | — |
| XENE | Xenon Pharmaceuticals Inc. - Common Shares | $5.6B | — | — |
| XERS | Xeris Biopharma Holdings, Inc. - Common Stock | $1.3B | — | — |
| XFOR | X4 Pharmaceuticals, Inc. - Common Stock | $349.7M | — | — |
| XGN | Exagen Inc. - Common Stock | $69.9M | — | — |
| XLO | Xilio Therapeutics, Inc. - Common Stock | $45.5M | — | — |
| XNCR | Xencor, Inc. - Common Stock | $929.4M | — | — |
| XOMA | XOMA Royalty Corporation - Common Stock | $329.3M | 15.2 | — |
| XOMAO | XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | $329.3M | 15.2 | — |
| XOMAP | XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock | $329.3M | 15.2 | — |
| XRAY | DENTSPLY SIRONA Inc. - Common Stock | $2.2B | — | — |
| XRTX | XORTX Therapeutics Inc. - Common Stock | $5.5M | — | — |
| XTLB | XTL Biopharmaceuticals Ltd. - American Depositary Shares | — | — | — |
| YDES | YD Bio Limited - Ordinary Shares | $859.7M | — | — |
| ZBH | Zimmer Biomet Holdings, Inc. Common Stock | $18.8B | 26.7 | — |
| ZBIO | Zenas BioPharma, Inc. - Common Stock | $1.1B | — | — |
| ZJYL | JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares | $34.4M | 19.2 | 1 |
| ZLAB | Zai Lab Limited - American Depositary Shares | $15.3B | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. - common stock | $284.3M | — | — |
| ZTEK | Zentek Ltd. - common stock | $95.5M | — | — |
| ZTS | Zoetis Inc. Class A Common Stock | $50.3B | 18.8 | — |
| ZURA | Zura Bio Limited - Class A Ordinary shares | $488.8M | — | — |
| ZVRA | Zevra Therapeutics, Inc. - Common Stock | $676.1M | 8.1 | — |
| ZYBT | Zhengye Biotechnology Holding Limited - Ordinary Shares | $79.6M | 14.2 | — |
| ZYME | Zymeworks Inc. - Common Stock | $1.7B | — | — |
没有股票匹配您的筛选条件
请尝试调整搜索条件
加载更多股票...